Montelukast
- Resources
Health Canada has approved Singulair (montelukast sodium) for the relief of symptoms of allergic rhinitis in people ages 15 and older. Allergic rhinitis, also known as hay fever, affects 20 percent to 25 percent of people in Canada and up to 75 percent of people with asthma. If poorly managed, the condition can increase the likelihood of asthma attacks and asthma-related hospital visits.
Read moreMore information on "Montelukast"
From Our Experts
Is Less Asthma Medicine in Your Future?
Asthma control is possible for most people who have asthma. That means you can expect to live an active life without being bothered by... Read more »
The Economic Crisis May Hit Asthmatics Hard
How will asthma care and health be affected by the economy?It is clear that we are in the midst of difficult economic times. Some of us can... Read more »
Asthma in Infants and Children
Asthma is a disease that affects over 5% of Americans, many of which are infants and young children. This entry will discuss asthma and... Read more »
What You Need to Know About Asthma Drug Black Box Warnings
Black box warnings are a type of labeling that the Federal Drug Administration (FDA, for short) requires pharmaceutical companies to use... Read more »
From Our Sources
Singulair may be better for overweight patients
Scientists report that the asthma pill montelukast (Singulair) may work better for patients who are overweight or obese than inhaled asthma... Read more »
New study finds Singulair does not affect children's growth
Children who take Singulair (montelukast) do not experience adverse effects on growth when compared to children treated with inhaled corticosteroids... Read more »
Clinical trial: Use of intravenous MK0476 and Singulair in acu...
This is a study to evaluate the treatment of patients entering emergency rooms with asthma attacks when they are given an intravenous form of MK0476... Read more »
Clinical trial: Use of Flovent, Advair, and Singulair in treat...
This is a study to compare the effects of Flovent (fluticasone propionate), Advair (fluticasone propionate/salmeterol), and Singulair (montelukast)... Read more »
Clinical trial: Investigation of IV asthma treatment
This is a study to determine if patients entering an emergency room with asthma attacks might benefit from an IV dose of an approved drug with the... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
